US Stroke Incidence
~800K
Approximately 800,000 strokes occur annually in the US — the leading cause of long-term disability and the fifth leading cause of death. About 610,000 are first events and 185,000 are recurrent strokes.[1]
What Is It
Definition, mechanism, and the clinical reality of end-stage stroke at end of life. What the hospice team needs to understand on day one.
Severe Stroke Dysphagia
50–65%
50–65% of acute stroke patients have dysphagia; 40–50% of those aspirate. Dysphagia is the single most important determinant of post-stroke functional outcome and death in the hospice population.[2]
Recurrent Stroke Risk
~25%
Approximately 25% risk of second stroke within 5 years of first event. Each recurrence causes additive neurological disability. Recurrent stroke is one of the most common pathways to hospice enrollment in cerebrovascular disease.[3]
Pressure Injury Rate
25–40%
25–40% of severely disabled post-stroke patients develop pressure injuries — a direct consequence of hemiplegia, contracture, reduced sensation, and immobility. Prevention starts at enrollment, not at the first wound.[4]
Stroke is the sudden interruption of blood flow to a region of the brain — causing infarction from ischemia (85% of strokes) or hemorrhagic damage from vessel rupture (15%). The neurological consequences depend entirely on which brain region is affected. Middle cerebral artery territory strokes — the most common — produce contralateral hemiplegia, hemisensory loss, and in dominant hemisphere involvement, aphasia that eliminates the patient's ability to participate in their own medical decisions. Brainstem strokes produce cranial nerve deficits, severe dysphagia, ataxia, and in the most devastating cases, locked-in syndrome — full consciousness trapped in a body that cannot move or communicate beyond vertical eye movements. Cerebellar strokes cause ataxia and vertigo and can produce life-threatening posterior fossa edema. Large hemispheric strokes with malignant edema are among the most rapidly fatal neurological events in medicine.[1]
End-stage stroke in hospice is defined by one or more of: severe post-stroke disability with NIHSS >20 and poor functional prognosis; recurrent stroke with cumulative disability beyond rehabilitation recovery; malignant stroke with severe swelling and herniation risk; or aspiration pneumonia as the recurrent complication of severe post-stroke dysphagia. What makes stroke unique in hospice is the suddenness. Unlike cancer, heart failure, or dementia — where the family has months or years to adjust — stroke arrives without warning and transforms a person from full function to severe disability in hours. The family had no time to prepare, no advance directive to fall back on, and no prior conversation about what their loved one would have wanted. The hospice team inherits this crisis at intake.[5]
🧭 Clinical framing
Stroke is a vascular injury to the brain that produces sudden, permanent neurological deficit. The clinical picture at hospice enrollment is dominated by five challenges that define every visit: (1) dysphagia and aspiration risk — the swallowing failure that produces recurrent aspiration pneumonia and is the proximate cause of death in most post-stroke hospice patients; (2) immobility complications — pressure injuries, contractures, DVT risk, and the cascade of skin breakdown in a hemiplegic patient who cannot reposition; (3) communication loss — aphasia that eliminates the patient's ability to express preferences, report pain, or participate in decisions; (4) surrogate decision-making crisis — the family member making life-and-death decisions without guidance from the patient and often without any prior goals-of-care conversation; and (5) the grief of sudden catastrophic loss — a family processing the equivalent of a sudden death while the patient is still alive but profoundly changed.
"The stroke patient's family doesn't look like any other hospice family at intake. They're shell-shocked. Three weeks ago this person was driving, cooking, talking. Now they can't swallow their own saliva. Your first job isn't clinical — it's recognition. Say out loud what happened to them. Name the speed of it. They need someone to acknowledge that the ground disappeared under their feet before you start talking about comfort kits."
— Waldo, NP · Terminal2
How It's Diagnosed
Diagnostic workup, severity scales, and what to look for in hospice records. Most patients arrive with an established diagnosis — this section helps you read it.
CT Brain Without Contrast
- Gold standard first-line imaging — immediately available; detects hemorrhage (hyperdense lesion) within minutes; shows early ischemic changes after several hours[6]
- ASPECTS score (Alberta Stroke Program Early CT Score) — quantifies MCA territory ischemia on a 10-point scale; ASPECTS ≤5 predicts poor functional outcome and is a threshold for thrombectomy futility
- CT angiography — added for large vessel occlusion assessment; identifies ICA or MCA occlusion amenable to thrombectomy
- In hospice context: CT has typically been completed — review to understand stroke type, territory, and volume of tissue involvement
MRI Brain with DWI
- Gold standard for acute ischemic stroke detection — diffusion-weighted imaging (DWI) shows restricted diffusion within minutes of ischemia onset; superior sensitivity to CT[7]
- Superior for posterior fossa strokes and small lacunar infarcts that CT may miss entirely
- FLAIR sequences show chronic lesion burden — multiple old infarcts indicate cumulative vascular disease and recurrent stroke history
- MR angiography defines vessel anatomy — carotid and vertebral stenosis, aneurysms, vascular malformations
NIHSS & mRS — Severity & Function
- NIHSS (National Institutes of Health Stroke Scale) — standard acute severity measure; scores 0–42; mild <5; moderate 5–15; severe 15–24; very severe >25; NIHSS >20 with persistent deficit at 24 hours has very poor prognosis for independence[8]
- mRS (modified Rankin Scale) — functional outcome: 0 = no symptoms; 3 = moderate disability, some help; 4 = moderately severe, walking with assistance; 5 = severe, bedridden; 6 = death. Hospice patients are typically mRS 4–5
- Know the patient's admission NIHSS and current mRS — these define the trajectory and prognosis more accurately than any other assessment
Swallowing Assessment & Carotid Imaging
- Bedside swallowing assessment and formal videofluoroscopic swallowing study (VFSS) or fiberoptic endoscopic evaluation (FEES) — the most important functional assessment in post-stroke hospice[9]
- Silent aspiration is common — the patient who does not cough when aspirating is the highest pneumonia risk; bedside water swallow test sensitivity is only 70–80% for aspiration
- IDDSI diet classification — know the recommended texture level at discharge; reassess at hospice enrollment
- Carotid duplex ultrasound / CTA — defines degree of stenosis; relevant for understanding stroke mechanism; endarterectomy or stenting may have been performed or declined
💡 For families
The brain scans and tests your loved one had in the hospital told us exactly which part of the brain was injured and how severely. At this point, the diagnostic workup is complete — we are not looking for new things to test. We are using what we know to provide the best possible comfort care. The swallowing evaluation is the one test we may repeat at home because swallowing ability can change, and knowing the current level helps us keep your person safe and comfortable during meals.
Causes & Risk Factors
Stroke subtypes, vascular risk factors, and the racial disparities that shape who gets strokes and who gets optimal care.
Ischemic Stroke (85%)
- Atrial fibrillation — the most important cardioembolic cause; emboli from left atrial appendage thrombus; AF accounts for ~20% of ischemic strokes; anticoagulation prevents; the continuation decision is a primary hospice conversation[10]
- Large artery atherosclerosis — carotid and vertebral artery plaque; stenosis causing embolism or thrombosis; the most common mechanism of anterior circulation stroke
- Small vessel disease — lacunar infarcts from penetrating artery occlusion; hypertension-related lipohyalinosis; multiple lacunes cause vascular dementia
- Cardioembolism — AF, mechanical valves, dilated cardiomyopathy, valvular disease, PFO
- Cryptogenic (20–30%) — no identified cause; ESUS (embolic stroke of undetermined source) increasingly recognized
- Hypercoagulable states — antiphospholipid syndrome, factor V Leiden, protein C/S deficiency — particularly in younger stroke patients
Hemorrhagic Stroke (15%) & Risk Factors
- Intracerebral hemorrhage (ICH) — hypertensive vasculopathy is the most common cause; rupture of deep penetrating arteries; basal ganglia, thalamus, brainstem, cerebellum; amyloid angiopathy causing lobar ICH in elderly; anticoagulation-related ICH; volume is the primary determinant of outcome[11]
- Subarachnoid hemorrhage (SAH) — ruptured berry aneurysm; sudden severe "thunderclap" headache; high mortality and morbidity
- Hypertension — single most important modifiable risk factor; present in 70–80% of stroke patients
- Other vascular risk factors: diabetes mellitus, hyperlipidemia, tobacco smoking, obesity, physical inactivity, excessive alcohol, sleep apnea, prior TIA
❤️ For families: "Why did this happen?"
Stroke is a disease of blood vessels — not something anyone chose or caused. High blood pressure, heart rhythm problems, and vascular disease are the most common reasons. Many strokes happen despite years of treatment and medication compliance. This is not anyone's fault. There is nothing your family member did or failed to do that caused this to happen. Strokes happen because blood vessels age, weaken, and fail — and some people are more vulnerable than others based on genetics, blood pressure, and heart rhythm conditions that may have been present for decades.
⚕ Clinician note: Racial disparities in stroke
Black Americans have a stroke incidence 2× higher than white Americans, develop strokes at younger ages, and have higher stroke mortality. Hispanic Americans face 1.5× the stroke risk. These disparities are driven by higher rates of hypertension, diabetes, and obesity — themselves products of structural determinants including healthcare access, food environment, and chronic stress — compounded by documented disparities in acute stroke treatment (lower thrombolysis and thrombectomy rates), rehabilitation access, and palliative care referral. The hospice clinician must be aware that the post-stroke patient from a marginalized community may have experienced delayed acute treatment, inadequate secondary prevention, and limited rehabilitation — and may carry justified medical mistrust into the hospice relationship.[12]
Treatments & Procedures
Acute stroke treatments completed before hospice and secondary prevention medications to assess at enrollment. Understanding prior therapy helps anticipate complications.
Acute stroke treatment is completed before hospice enrollment — but the hospice clinician must understand what was done, what was declined, and what the outcomes were. The decision to pursue or forgo hemicraniectomy, thrombolysis, or thrombectomy may be the most ethically fraught decision in the patient's medical history, and the family may still be processing it at intake.[13]
Acute Stroke Treatments
- IV thrombolysis (alteplase/tenecteplase) — within 4.5 hours for ischemic stroke; know if administered — post-thrombolysis hemorrhagic transformation affects subsequent anticoagulation decisions[14]
- Mechanical thrombectomy — endovascular clot removal within 6–24 hours for large vessel occlusion; the most effective acute stroke treatment; know if performed and the result
- Decompressive hemicraniectomy — for malignant MCA infarction; surgical removal of bone flap to allow swelling; reduces mortality dramatically but survivors often have severe disability (mRS 4–5); the decision to proceed or decline is among the most ethically complex in neurology[15]
- Neurosurgical evacuation — for select ICH; VP shunt — for hydrocephalus from SAH or cerebellar stroke
Secondary Prevention & Palliative Procedures
- Antiplatelet therapy — aspirin, clopidogrel, aspirin-dipyridamole for non-cardioembolic stroke; reassess at hospice enrollment for bleeding risk vs prevention benefit[16]
- Anticoagulation — warfarin or DOAC for AF-related stroke; the most important medication continuation decision at enrollment; apixaban preferred for lowest bleeding risk
- Antihypertensives — ACE inhibitors, ARBs, calcium channel blockers, thiazides; target reassessment based on functional status and goals
- Statins — high-dose atorvastatin (SPARCL trial evidence); deprescribing candidate in comfort-focused care[17]
- PEG tube placement — for medication delivery and nutrition in severe dysphagia; the most common palliative procedure decision in post-stroke hospice
- Botulinum toxin injections — for focal spasticity management; outpatient; hospice-compatible
When Therapy Makes Sense
Evidence-based criteria for continuing secondary prevention and active management in post-stroke hospice patients. Not about holding on — about reading the data correctly.
Not every post-stroke hospice patient should have all secondary prevention medications stopped at enrollment. Some treatments remain comfort-serving even in a hospice framework. The clinical obligation is to assess each medication and intervention individually against the patient's functional status, life expectancy, goals, and symptom profile.[16]
- 01Anticoagulation continuation for AF-related stroke (life expectancy >3 months, mRS 4): A second cardioembolic stroke in an already disabled patient further reduces quality of life significantly. If the patient tolerates a DOAC without significant bleeding risk and has months of meaningful life, anticoagulation continuation reduces the risk of additional neurological injury. Apixaban preferred for lowest bleeding risk.[10]
- 02Antihypertensive continuation at liberalized targets: A patient who is still ambulatory with assistance benefits from BP control to prevent recurrent stroke. Target <140/90 mmHg in ambulatory patients. Less stringent targets in fully bedbound patients where hypotension causes falls and syncope.[18]
- 03Dysphagia management with modified textures and SLP guidance: Even in comfort-focused goals, optimizing swallowing reduces aspiration frequency and extends the pleasure of oral eating. Request SLP evaluation at enrollment for any patient with dysphagia.[9]
- 04Spasticity management with baclofen and physical therapy: Spasticity causes severe pain, prevents comfortable positioning, and drives pressure injury risk through abnormal posture. Treat aggressively at every enrollment where spasticity is present.[19]
- 05Post-stroke depression treatment with SSRI: Depression occurs in 30–40% of stroke survivors and dramatically reduces quality of life and any remaining functional capacity. Sertraline or escitalopram. Treat at every enrollment where depression is present — this is a comfort intervention.[20]
- 06Seizure management continuation: Levetiracetam continuation if post-stroke seizures have occurred. Seizure control is a comfort obligation. Breakthrough seizure at home without rescue medication available is a preventable crisis.
- 07Pressure injury wound care: Evidence-based wound care reduces pain, odor, and infection. Repositioning protocol and pressure redistribution mattress from day one. This is clinical prevention, not optional care.
- 08Bowel and bladder management: Constipation causes pain and autonomic symptoms; bladder management prevents UTI. Both are clinical obligations regardless of goals-of-care status.
When It Doesn't
Knowing when to deprescribe secondary prevention is not clinical failure. It is the most important medication decision in post-stroke hospice.
The most common medication error in post-stroke hospice is continuing a complex secondary prevention regimen designed for a patient who had functional recovery potential — in a patient who now has mRS 5 and comfort-only goals. The cardiologist started these medications. No one has discussed stopping them. The hospice team must initiate this conversation.[21]
- 01Anticoagulation discontinuation when life expectancy <1–3 months: Stroke prevention benefit requires survival to benefit. A patient expected to live weeks does not benefit from ongoing anticoagulation but carries ongoing bleeding risk — including the catastrophic risk of anticoagulation-related ICH. Prior serious bleeding event or ICH is an absolute contraindication regardless of AF status.[21]
- 02Antihypertensive discontinuation in fully bedbound patients: When the patient is fully bedbound, no longer ambulatory, and secondary prevention of stroke is no longer the goal — hypotension from antihypertensives causes orthostatic symptoms, falls in any remaining mobility, and contributes to fatigue. Liberalize aggressively; often discontinue entirely.[18]
- 03All secondary prevention medications (statins, antiplatelet, anticoagulant) in final weeks to months with mRS 5 and comfort-only goals: The benefit horizon of secondary prevention exceeds the expected survival. The monitoring burden (INR checks, BP monitoring, labs) exceeds benefit. Pill burden is significant and may worsen already-difficult medication administration through PEG or crushed formulations.
- 04High-dose corticosteroids for cerebral edema in massive hemispheric stroke: In a patient who has chosen comfort-focused goals, aggressive edema management with high-dose dexamethasone is inconsistent with comfort framing. Moderate-dose dexamethasone for headache and nausea symptom management may be appropriate — but the goal is comfort, not edema reduction.
- 05Tube feeding in severe post-stroke dysphagia when the only stated goal is aspiration prevention: The evidence does not support PEG for aspiration prevention in severe dysphagia from stroke. The FOOD trial demonstrated no survival benefit from early PEG placement. A PEG tube does not prevent aspiration — patients aspirate oral secretions, refluxed gastric contents, and tube feed regardless of tube placement. The conversation must be had: a family that insists on PEG to "prevent aspiration" must be told clearly and compassionately that the tube does not accomplish this goal.[22]
- 06Aggressive DVT prophylaxis with injectable anticoagulants: In a patient with comfort-only goals and mRS 5, the daily injections of enoxaparin cause pain and bruising without serving comfort goals. Mechanical compression and positioning are reasonable alternatives if DVT prevention is desired.
📋 Clinician note: The tube feeding conversation
The family asking for a feeding tube in severe post-stroke dysphagia is not asking for nutrition — they are asking for control over an uncontrollable situation. They are asking to do something when everything else has been taken from them. The correct clinical response is not to refuse the tube — it is to provide accurate information about what the tube does and does not accomplish, then support the family's decision. What PEG does provide: reliable medication delivery route, supplemental nutrition, a sense of "doing something." What PEG does not provide: aspiration prevention, restoration of swallowing, or prolonged survival in severe post-stroke dysphagia. Let the family decide based on accurate information.
Out-of-the-Box Approaches
Evidence-graded integrative and interventional approaches for post-stroke hospice. Grade A = RCT; B = multi-observational/meta-analysis; C = limited clinical; D = expert opinion.
SSRI for Post-Stroke Depression & Emotionalism
Grade ASertraline 50 mg daily or Escitalopram 10 mg daily; titrate after 2–4 weeks
Post-stroke depression affects 30–40% of survivors and is one of the most treatable and most undertreated comorbidities. SSRIs reduce depression and also reduce emotionalism — pathological laughing and crying from loss of cortical inhibition of limbic expression. The FLAME trial demonstrated fluoxetine improved motor recovery and reduced depression after ischemic stroke. Post-stroke emotionalism causes profound social isolation, caregiver distress, and patient shame. Treatment with SSRI is effective, well-tolerated, and should be initiated at every enrollment where these symptoms are present.[20]
Botulinum Toxin for Focal Post-Stroke Spasticity
Grade AOnabotulinumtoxinA injected into spastic muscle groups; effects last 3–4 months; outpatient procedure
Intramuscular botulinum toxin injections to spastic muscle groups — typically elbow flexors, wrist/finger flexors, and ankle plantar flexors in the hemiplegic limb — reduce focal spasticity, prevent contracture, reduce pain, and improve hygiene and positioning. The hemiplegic arm contracted into the chest causing skin maceration and shoulder pain is a treatable condition regardless of hospice enrollment. Refer to physiatry or neurology at enrollment for evaluation. AAN practice guideline supports use for upper and lower limb spasticity.[23]
Pressure Redistribution from Day One
Grade AHigh-specification alternating pressure mattress + repositioning every 2 hours documented and delegated
The immobile stroke patient with hemiplegia and reduced sensation is at the highest pressure injury risk in all of hospice. A high-specification alternating pressure mattress prescribed at enrollment and repositioning every 2 hours — documented and delegated to family with explicit supervision protocol — prevents the majority of pressure injuries. A stage 4 pressure injury in a hemiplegic post-stroke patient is one of the most painful and treatment-resistant wounds in hospice. Prevent it from day one with clinical urgency. NICE guidelines and Cochrane reviews support alternating pressure surfaces over standard foam.[4]
Family Communication Training for Aphasia
Grade BStructured SLP-guided training; 2–3 sessions at enrollment; communication boards and adapted techniques
The family that learns to communicate with an aphasic patient using yes/no questions, picture boards, gesture recognition, and patience transforms both the caregiving experience and the patient's quality of life. Communication partner training is an evidence-based intervention that reduces communication breakdown, decreases caregiver frustration, and preserves the patient's participation in their own care. SLP referral at enrollment for family training — not just swallowing assessment — is the standard of care.[24]
Music Therapy for Post-Stroke Recovery & Comfort
Grade BStructured music therapy sessions; familiar music playlist for daily use; 30–60 min sessions
Music therapy reduces anxiety, agitation, and depression in post-stroke patients. Familiar music activates preserved neural pathways even in patients with severe aphasia and cognitive impairment. Music-based interventions improve mood, reduce behavioral symptoms, and provide a connection pathway when verbal communication is lost. In the hospice setting, a personalized music playlist is both therapeutic and a bridge between the patient and family.[25]
Nuedexta for Pseudobulbar Affect
Grade BDextromethorphan/quinidine (Nuedexta) 20/10 mg BID
FDA-approved for pseudobulbar affect (PBA) — the pathological laughing and crying from disruption of corticobulbar tracts. When SSRIs are insufficient for emotionalism, Nuedexta provides targeted symptomatic relief. Significant improvement in episodes of uncontrolled emotional expression. Insurance coverage can be a barrier — prior authorization often required. Well-tolerated; QT prolongation monitoring recommended at initiation.[26]
Therapeutic Positioning Program
Grade BPT/OT-designed positioning protocol; custom pillow placement; 2-hour rotation schedule
Structured therapeutic positioning reduces spasticity-related pain, prevents contracture progression, decreases pressure injury risk, and improves respiratory function. The hemiplegic limb must be supported in a functional position — the affected shoulder subluxation is a common source of severe pain that is often unrecognized. PT/OT consultation at enrollment for positioning protocol that family can execute independently is standard of care for post-stroke hospice patients.
Natural & Herbal Options
Evidence grading, dosing, drug interaction flags, and contraindications specific to post-stroke patients on complex cardiovascular medication regimens.
⚠ Critical: Drug Interaction Landscape in Post-Stroke Patients
Post-stroke patients are almost universally on multiple cardiovascular medications — antiplatelets, anticoagulants, antihypertensives, and statins — creating a complex drug interaction landscape for supplements. Anticoagulation for AF-related stroke creates specific bleeding risk amplification from antiplatelet supplements. Dysphagia means many supplements cannot be safely swallowed and must be verified for tube compatibility or reformulated as liquids. Three questions before every supplement in post-stroke hospice: (1) Does this interact with antiplatelet or anticoagulant therapy? (2) Can it be safely swallowed or administered via PEG? (3) Does it affect blood pressure?
"The stroke patient's family is going to show up with a bag of supplements from the health food store because someone told them CoQ10 or fish oil would help. Don't dismiss them — check the bag. A patient on warfarin who starts taking high-dose fish oil, vitamin E, and ginkgo is a bleeding emergency waiting to happen. Ask what they're taking, check every one against the anticoagulant, and explain why it matters."
— Waldo, NP
| Herb / Supplement | Evidence Grade | Typical Dose | Potential Benefit | ⚠ Interactions / Contraindications |
|---|---|---|---|---|
| Coenzyme Q10 | Grade C | 100–200 mg daily | Mitochondrial support in post-stroke neuronal recovery; modest evidence in cerebrovascular disease; antioxidant neuroprotection | Minor warfarin interaction — may reduce INR; monitor if on warfarin. Minimal interaction with antiplatelet therapy at standard doses. PEG-compatible in liquid formulation. Reasonable to continue if already taking. |
| Magnesium glycinate | Grade C | 200–400 mg daily | Neuroprotective properties; magnesium deficiency common post-stroke with diuretic use; may reduce spasticity and muscle cramping; supports sleep | Check renal function — accumulates in renal failure. No antiplatelet interaction at standard dose. PEG-compatible. May potentiate antihypertensive effect — monitor BP. |
| Melatonin | Grade C | 3–10 mg at bedtime | Sleep disruption from post-stroke circadian dysregulation, pain, and depression; neuroprotective signal in experimental stroke models; improves sleep quality | No antiplatelet or anticoagulant interaction. PEG-compatible in liquid formulation. One of the safer supplements in this population. May potentiate sedating medications. |
| Omega-3 fatty acids | Grade C | 1 g/day (food-source level only) | Anti-inflammatory; cardiovascular benefit at dietary intake levels; may support endothelial function | ⚠ High doses (>3 g/day) increase bleeding risk — especially with anticoagulants or antiplatelets. At 1 g/day from food sources, minimal risk. Liquid formulation for PEG. Do not recommend high-dose supplementation in anticoagulated patients. |
| Vitamin D | Grade C | 1000–2000 IU daily | Deficiency universal in bedbound patients; may support immune function and reduce infection risk; bone health in immobilized patients | Minimal drug interactions. PEG-compatible in liquid drops. Check 25-OH vitamin D level if accessible. Do not exceed 4000 IU daily without monitoring. |
| B-complex vitamins | Grade C | Standard B-complex daily | Homocysteine reduction (elevated homocysteine is a stroke risk factor); B12 deficiency screening appropriate; folate and B6 support methylation pathways | Generally safe. PEG-compatible in liquid. B6 >100 mg/day can cause peripheral neuropathy — do not exceed standard doses. No significant anticoagulant interaction. |
🚫 Avoid in Post-Stroke Patients
- Ginkgo biloba: Potent antiplatelet effect — increases bleeding risk significantly in patients on aspirin, clopidogrel, or anticoagulants. Multiple case reports of serious bleeding events including intracranial hemorrhage. Absolutely contraindicated in anticoagulated post-stroke patients.
- Garlic supplements (high-dose): Antiplatelet and mild anticoagulant effect at supplemental doses. Increases bleeding risk with concurrent antiplatelet or anticoagulant therapy. Dietary garlic in food is not a concern — high-dose supplements are.
- Ginseng (Panax): Variable effects on blood pressure and anticoagulation; may reduce warfarin effectiveness (CYP induction) or increase bleeding with other agents. Unpredictable interaction profile makes it unsuitable for patients on complex cardiovascular regimens.
- St. John's Wort: Major CYP3A4 and P-glycoprotein inducer — reduces levels of warfarin, DOACs (apixaban, rivarelbaan), calcium channel blockers, statins, and many antihypertensives. Critically dangerous in post-stroke patients on these medications. Absolutely contraindicated.
- Vitamin E (high-dose >400 IU): Antiplatelet effect at high doses — increases hemorrhagic stroke risk. Meta-analysis suggests increased all-cause mortality at doses >400 IU/day. Do not recommend in post-stroke patients.
Timeline Guide
A guide, not a prediction. Stroke trajectory begins with sudden catastrophic injury — the phases reflect recovery plateau, recurrence pattern, and complications trajectory.
Two distinct populations reach hospice from stroke: (1) the patient with severe acute stroke directly admitted to hospice without recovery potential — often from a malignant MCA infarction or large ICH where the family declined aggressive surgical intervention; and (2) the patient with prior stroke(s) who has accumulated disability through recurrent events to the point of hospice-level care needs. The timeline below addresses both trajectories.[5]
YRS–
MOS
MOS
Stable Chronic Stroke Disability
- Prior stroke with mRS 3–4; rehabilitation plateau reached; living with permanent neurological deficits — hemiparesis, mild dysphagia, partial aphasia
- Secondary prevention ongoing — antiplatelets or anticoagulation, antihypertensives, statin; managing spasticity at stable level; dysphagia managed with modified diet
- Pressure injury prevention routine established; ambulatory with assistance or wheelchair-dependent but community-participating
- This phase can last years — the patient has adjusted to disability and is living with maximal function. Palliative care integration is rarely offered at this stage
- Critical gap: The advance directive conversation that would make the recurrent stroke decision-making so much easier has almost never been had
MOS–
1 YR
1 YR
Recurrence Adding to Disability
- First or second recurrent stroke adding to neurological deficit; mRS declining from 3 to 4 to 5; dysphagia worsening; cognitive function declining from cumulative lacunar disease or vascular dementia
- Caregiver burden increasing exponentially; hospitalization for stroke and rehabilitation less productive with each recurrence
- Weight loss beginning from increasing dysphagia and reduced oral intake; spasticity worsening in hemiplegic limbs; depression deepening
- This is the most important palliative integration window and it is essentially never offered. The patient who has had two strokes and is heading toward a third deserves an explicit conversation about what they would want if the next stroke eliminates all communication[27]
WKS–
MOS
MOS
Severe Disability with Recurrent Aspiration
- mRS 5 — completely dependent; dysphagia severe with recurrent aspiration pneumonia; PEG tube placed or being discussed; communication severely impaired or absent
- Hospice enrollment appropriate — either from accumulation of recurrent strokes or from a single severe event with poor recovery trajectory
- Dominant clinical challenges: aspiration pneumonia management, pressure injury prevention, spasticity/pain control, medication route decisions, surrogate decision-making support
- Secondary prevention deprescribing conversation with family — explain why medications are being adjusted; document decisions thoroughly
- Comfort kit assembly: morphine for dyspnea, glycopyrrolate for secretions, lorazepam for anxiety, midazolam for emergency seizure or agitation
DAYS–
WKS
WKS
Active Decline — Pre-Active Phase
- Increasing somnolence; oral intake declining to minimal or nil; swallowing becoming unsafe even for medications and thickened liquids
- Recurrent fevers from aspiration or UTI; skin breakdown accelerating despite prevention measures; spasticity may decrease as neurological function declines further
- Medication route conversion: oral to PEG (if present), sublingual, or subcutaneous for all essential comfort medications
- Family preparation for the final phase: what active dying looks like in stroke — breathing changes, further decrease in consciousness, potential for terminal seizure
- Ensure midazolam and morphine are drawn, labeled, and at bedside with clear family instructions before crisis occurs
HRS–
DAYS
DAYS
Final Hours
- Cheyne-Stokes or agonal breathing; mandibular breathing; mottling of extremities beginning at knees and feet
- Unresponsive or minimally responsive — auditory awareness may persist; continue speaking to the patient; familiar voices and music remain therapeutic
- Stroke-specific risks: terminal seizure (have buccal midazolam at bedside — 5–10 mg buccal, repeat once if needed); sudden respiratory failure from brainstem compression or aspiration; recurrent stroke causing rapid progression
- Terminal secretions management: glycopyrrolate 0.2 mg SQ q4h or hyoscine patch; gentle repositioning; educate family that the "death rattle" sounds worse than it feels to the patient
- Family presence guidance: sit close, hold the unaffected hand, speak normally, play familiar music. Say what needs to be said. Give permission to go.
Medications to Anticipate
Symptom-targeted pharmacology for end-stage stroke. What to have in the comfort kit, what to titrate first, and what the evidence supports.
⚕ Three Simultaneous Assessments at Enrollment
(1) Secondary prevention medications — which are still serving comfort goals and which should be deprescribed; (2) Swallowing route — can medications be given orally, and if not, what is the PEG, sublingual, or SQ alternative for each essential medication; (3) Drug interactions — the post-stroke patient typically has multiple cardiovascular agents with complex interactions. The most common medication error in post-stroke hospice is continuing complex secondary prevention regimens in a patient with mRS 5 and comfort-only goals while failing to have morphine, lorazepam, and glycopyrrolate immediately available for the respiratory crisis that will almost certainly come.
| Drug | Class / Target Symptom | Starting Dose | Notes / Cautions |
|---|---|---|---|
| Morphine | Opioid / Dyspnea + Pain | 2.5–5 mg PO/PEG q4h; 1–2 mg SQ q4h | The most common comfort medication needed at end-stage stroke. Primary indication: dyspnea from aspiration pneumonia. Also for pain from spasticity and immobility. SQ conversion when oral/PEG route is compromised. The family must have this medication available before the aspiration pneumonia arrives.[28] |
| Levetiracetam | Anticonvulsant / Post-stroke seizures | 500–1000 mg BID PO/PEG | Liquid formulation for PEG; renal dose adjustment. Continue if post-stroke seizures have occurred. Buccal midazolam or rectal diazepam for acute rescue at home. ⚠ Do not abruptly discontinue Behavioral side effects (agitation, irritability) more common in brain-injured patients |
| Baclofen | Muscle relaxant / Spasticity | 5 mg TID PO/PEG; titrate to 10–20 mg TID | Reduces painful muscle overactivity; prevents contracture progression; liquid PEG formulation available. ⚠ Do not stop abruptly — withdrawal causes seizures and autonomic instability. Max 80 mg/day. Sedation is dose-limiting. |
| Sertraline or Escitalopram | SSRI / Depression + Emotionalism | Sertraline 25–50 mg daily; Escitalopram 5–10 mg daily via PEG | Post-stroke depression and pseudobulbar affect. Sertraline liquid available for PEG. Takes 2–4 weeks for full effect — initiate at enrollment, not at crisis. Also reduces pathological crying/laughing. Check for SSRI-antiplatelet interaction (increased bleeding risk with concurrent aspirin).[20] |
| Glycopyrrolate | Anticholinergic / Secretions + Drooling | 0.2 mg SQ q4h; or 1 mg PO/PEG TID | Preferred over hyoscine in conscious patients — no CNS effects. Reduces oral secretions (drooling from facial weakness) and terminal respiratory secretions. Also useful for sialorrhea from reduced oral motor control.[28] |
| Lorazepam | Benzodiazepine / Anxiety | 0.5–1 mg PO/SL/SQ q4–6h PRN | For anxiety, agitation, adjunctive for dyspnea with anxiety component. Sublingual route available when PO is compromised and PEG is not present. Use cautiously — may worsen confusion in patients with vascular cognitive impairment. |
| Midazolam | Benzodiazepine / Emergency seizure + Terminal agitation | 2.5–5 mg SQ/buccal PRN; repeat in 10 min if needed | Must be in comfort kit drawn and labeled. Primary emergency use: breakthrough seizure when PO route unavailable. Also for terminal agitation and catastrophic symptom management. Buccal route for family administration during seizure. ⚠ Have at bedside before crisis occurs |
| Hyoscine (Scopolamine) | Anticholinergic / Terminal secretions | 1.5 mg patch q72h; or 0.4 mg SQ q4h | Alternative to glycopyrrolate for terminal secretions. Patch is convenient for family administration. CNS effects (sedation, confusion) may be beneficial or problematic depending on patient status. Combine with repositioning. |
| Metoclopramide | Prokinetic / Nausea + Gastroparesis | 10 mg PO/PEG q6h; 5–10 mg SQ q6h | For nausea from gastroparesis and reduced GI motility common in immobilized stroke patients. Also improves tube feed tolerance via PEG. ⚠ Extrapyramidal side effects — use cautiously in brain-injured patients; avoid with dopamine antagonists |
| Senna + Docusate | Laxative / Constipation | Senna 8.6–17.2 mg + Docusate 100 mg BID | Mandatory with any opioid initiation. Immobility, reduced fluid intake, and opioid use make constipation universal. PEG-compatible in liquid formulations. Titrate to at least one bowel movement every 2–3 days. Add bisacodyl suppository or MiraLax if inadequate. |
| Oxybutynin | Anticholinergic / Urinary urgency | 5 mg PO/PEG BID–TID | For neurogenic bladder overactivity and urgency incontinence. Reduces catheter-related bladder spasm. CNS side effects (confusion) limit use in cognitively impaired patients — consider topical formulation. Extended-release preferred for fewer side effects. |
| Acetaminophen | Analgesic / Mild pain + Fever | 650–1000 mg PO/PEG q6h; rectal 650 mg q6h | First-line for mild pain and fever management. Rectal route when PO/PEG unavailable. Important for fever control in recurrent aspiration pneumonia. Avoid exceeding 3 g/day in frail elderly; 2 g/day if hepatic impairment. |
| Dexamethasone | Corticosteroid / Cerebral edema + Comfort | 4–8 mg PO/PEG/SQ daily; taper as able | For cerebral edema-related headache, nausea, and increased ICP symptoms in massive stroke. Appetite stimulation and general well-being improvement. Monitor glucose. Taper if >2 weeks. Not for long-term use in hospice without clear comfort indication. |
| Nystatin | Antifungal / Oral candidiasis | 5 mL swish-and-swallow QID; or PEG | Oral thrush is extremely common in dysphagic stroke patients with poor oral hygiene, steroid use, and antibiotic exposure from recurrent pneumonia treatment. Daily oral care and nystatin prophylaxis reduce incidence. PEG-compatible. |
🌿 Symptom Management Decision Tree
Evidence-based · Stroke-specific · Hospice-adaptedSelect a symptom below to begin
What is the primary symptom to address?
🚨 Comfort Kit Must-Haves for Stroke
Before aspiration pneumonia: Morphine 2.5–5 mg SQ PRN (dyspnea); Glycopyrrolate 0.2 mg SQ (secretions). Before seizure: Midazolam 5 mg buccal/SQ, pre-drawn and labeled — family trained on buccal administration. Before terminal agitation: Haloperidol 1 mg SQ + Midazolam 2.5 mg SQ. Before respiratory crisis: Morphine + Lorazepam 0.5 mg SL/SQ at bedside with clear written instructions. These medications must be in the home and family-instructed before the first aspiration pneumonia episode, not during it.
Clinician Pointers
High-yield clinical pearls for post-stroke hospice. The things not in the textbook — learned at the bedside over years of clinical experience with this specific population.
1
Aphasia does not mean the patient cannot be consulted
The most important clinical error in post-stroke hospice is treating the aphasic patient as if they have no opinions, preferences, or experiences worth soliciting. Many aphasic patients have intact receptive language and can answer yes/no questions reliably. Many more retain emotional processing and can express distress, comfort, preference, and connection through facial expression, vocalization, and gesture. Use adapted communication at every visit — simple yes/no questions, picture boards, clear facial communication, allowing extra time. Explicitly advocate for the patient's continued participation in decisions about their care despite the communication impairment. Model this for the family — they will learn from you.
2
Silent aspiration is the most dangerous diagnostic trap
The absence of coughing does not mean swallowing is safe. The brain regions damaged in stroke often include the cortical and subcortical circuits that generate the cough reflex. The patient who aspirates silently is at the highest risk of aspiration pneumonia precisely because there is no clinical signal. Look for indirect signs: wet vocal quality after eating, low-grade recurrent fevers, nocturnal cough, unexplained weight loss, oxygen desaturation after meals. Formal swallowing assessment at enrollment is not optional — bedside water swallow test misses 20–30% of aspiration. If VFSS or FEES has been done, know the results. If not, request SLP evaluation and manage based on highest risk until assessed.[9]
3
Secondary prevention deprescribing is your clinical job
The patient with mRS 5 on a statin, an antiplatelet, an antihypertensive, and two other secondary prevention agents prescribed after their first stroke five years ago has a medication list that does not reflect their current clinical reality. Review every medication at enrollment and deprescribe with documentation and explanation. The monitoring burden (INR, BP checks, labs) and pill burden reduction is itself a comfort intervention. The cardiologist or neurologist who prescribed these medications did so for a patient with different goals — your job is to align the medication list with the current goals of care.
4
The surrogate decision-maker needs explicit support
The family member making decisions for a stroke patient who cannot speak is carrying the heaviest burden in all of hospice care. Unlike families of dementia patients who have watched gradual decline, the stroke surrogate was thrust into this role suddenly without preparation. They almost never had the advance directive conversation. Help them construct substituted judgment: "Not what you want — what your person would have wanted. What did they value? What would they say if they could see themselves now?" Provide this guidance at every visit. Reassure them that deciding based on everything they knew about their person is an act of love, not a burden to carry with guilt.[29]
5
Pressure injury prevention is a clinical emergency from day one
The hemiplegic patient who cannot reposition, cannot feel the affected side, and has reduced tissue perfusion from immobility is a pressure injury developing in real time. Do not wait for the first red mark to act. At enrollment: order alternating pressure mattress; establish 2-hour repositioning schedule documented and delegated; inspect sacrum, heels, greater trochanters, and scapulae at every visit; float heels with pillows; ensure adequate nutrition for tissue integrity. A stage 4 sacral ulcer in a post-stroke patient is a failure of prevention, not an inevitable outcome.[4]
6
The recurrent stroke conversation must happen explicitly
A post-stroke patient with significant residual disability is at 25% risk of another stroke within 5 years. If another stroke occurs, what does the family want? Hospital transfer? Comfort at home? Thrombolysis attempt? This conversation must happen at enrollment when there is time to think — not during a new neurological event when the family is panicking. Document the decision. For patients already at mRS 5, the decision to manage a recurrent stroke at home with comfort measures only is often appropriate and should be discussed explicitly.
7
PEG evidence must guide the tube feeding conversation
The FOOD trial evidence is clear: early PEG does not improve outcomes in post-stroke dysphagia compared to nasogastric feeding, and neither tube type prevents aspiration. When the family asks about PEG, lead with the evidence: the tube provides a reliable medication route and supplemental nutrition, but it does not prevent aspiration pneumonia. Patients aspirate oral secretions and refluxed tube feed regardless of tube placement. Present the facts, then support the family's decision — many families choose PEG for medication delivery and partial nutrition even knowing the aspiration evidence, and that is a valid informed choice.[22]
8
Post-stroke depression screening is a clinical obligation
Depression affects 30–40% of stroke survivors and is systematically underdiagnosed — partly because the symptoms overlap with stroke-related disability (fatigue, apathy, sleep disruption, appetite loss) and partly because clinicians assume sadness is "appropriate" and therefore untreatable. Screen every patient at enrollment. The single-question screen — "Are you depressed?" — has high sensitivity in stroke populations. For aphasic patients, use behavioral indicators: withdrawal, tearfulness, refusal of care, sleep-wake disruption. Treat with sertraline or escitalopram — onset takes 2–4 weeks, so initiate at enrollment. Depression treatment is a comfort intervention.[20]
"I have never once regretted ordering the alternating pressure mattress at enrollment. I have regretted every time I didn't. By the time you see the stage 2, you are three weeks behind on prevention. And the family — who is already overwhelmed by everything else this stroke has done — now has a wound to dress on top of it all. Prevent it. Day one. No exceptions."
— Waldo, NP
Psychosocial & Spiritual Care
The grief of sudden catastrophic loss, surrogate decision-making burden, aphasia isolation, and the specific spiritual crisis of stroke at end of life.
Stroke produces a unique psychosocial crisis that no other hospice diagnosis replicates. The catastrophic suddenness — from full function to severe disability in hours — means the family has experienced what is functionally a sudden death while the patient is still alive. They are grieving a person who is present but profoundly changed. The patient, if aware, is grieving their own identity, independence, and voice. And both are navigating this grief while simultaneously making the most consequential medical decisions of their lives without any prior preparation.[29]
Stroke-Specific Psychosocial Themes
The Shock of Sudden Catastrophic Loss
Unlike cancer or progressive neurological disease where there is time to prepare, stroke arrives without warning and transforms a person in hours. The family at hospice intake is often still in acute shock — they may have been managing acute inpatient care for weeks before reaching home hospice and have had no time to process what happened. The hospice clinician who acknowledges this explicitly — "You didn't have time to prepare for any of this — the stroke came without warning and everything since then has been one crisis after another" — provides recognition of the specific trauma of sudden neurological catastrophe that most clinical interactions have missed.
Surrogate Decision-Making Guilt
The family member making medical decisions for a stroke patient who cannot speak carries a burden that many describe as the most difficult experience of their life. They are making decisions that may end or extend a life without knowing what the patient would have wanted. They second-guess every choice. Provide regular reassurance: "You are not deciding what you want — you are doing the hardest possible thing, which is deciding what your person would have wanted based on everything you knew about them. That is an act of extraordinary love, not a burden you should carry with guilt."
The Relationship Severed Without Warning
In long progressive diseases, the relationship between the patient and family evolves slowly — there is time for final conversations, expressions of love, reconciliation. In stroke, all of that was lost instantly. The family member who last spoke with their person at breakfast before the stroke is living with the loss of every conversation they will never have. The hospice clinician must name this: "The stroke took away your ability to have the conversations you needed to have. That loss is real and it deserves to be grieved." Then offer what is still possible: hand-holding, music, presence, adapted communication.
Aphasia Isolation & Identity After Stroke
The aphasic patient who is cognitively aware but cannot express thoughts, preferences, or emotions through language is experiencing a form of isolation that is difficult to overstate. Their identity — built over decades of relationships, conversations, and self-expression — has been severed from its primary channel. For patients with awareness, this is a source of profound existential suffering. The hospice team must actively work to maintain the patient's personhood: use their name, ask their opinion through adapted means, talk to them directly (not about them), and remind the family that the person they love is still present even when words are not.
Tube Feeding Grief & Depression Screening
The tube feeding decision in stroke carries enormous emotional weight. For many families, the PEG tube represents the final acknowledgment that their person cannot do the most basic human act — eat. The family that has been hand-feeding pureed foods with love and patience for weeks must now accept that even this connection point may be lost. The decision to place or decline a PEG is not merely medical — it is a grief milestone. Support the family through this decision regardless of the outcome.
Post-stroke depression screening must occur at every enrollment. Use the single-question screen for verbal patients: "Are you depressed?" For aphasic patients, use behavioral indicators — withdrawal from available interaction, tearfulness, sleep-wake disruption, refusal of previously enjoyed activities. PHQ-2 adapted for yes/no response in patients with expressive aphasia. Treat with sertraline or escitalopram — onset 2–4 weeks; initiate at enrollment.[20]
Spiritual Assessment & Goals-of-Care
The spiritual crisis of stroke is the crisis of meaning in the face of sudden, unexplained catastrophe. "Why did this happen?" is both a medical question and a spiritual one. Use the FICA framework: Faith/beliefs, Importance, Community, Address. For many patients of faith, the stroke challenges theological assumptions about fairness, divine protection, and the meaning of suffering. Chaplain referral at enrollment — not at crisis. For the patient who cannot speak, spiritual care is delivered through presence, familiar prayers or readings, music from their tradition, and the maintenance of rituals that mattered to them before the stroke.
Clinical Pearl
"The family sitting in the hospice home after a catastrophic stroke has been through the medical system at its most intense — the ER, the stroke unit, the ICU, the rehab facility — and at every stage, someone was doing something. Now they're home, and we're the only team left, and the doing is different. The hardest thing we ask them to accept is that presence is an intervention. Sitting with their person, holding their hand, playing their music — that is not doing nothing. That is doing the most important thing left to do."
"The stroke family carries a specific kind of guilt I don't see in any other diagnosis. They feel guilty for decisions they made — or didn't make — in the first 24 hours when everything was chaos. 'Should I have pushed harder for the surgery? Should I have said no to the surgery? Why didn't I notice the symptoms earlier?' You have to name this directly and release them from it. The decisions they made were the best decisions available with the information they had at the time. Period. Say it out loud. Say it more than once."
— Waldo, NP · Terminal2
Family Guide
Plain language for families navigating post-stroke care at home. Share, print, or read aloud at the bedside.
You are caring for someone who has experienced one of the most sudden and life-changing events in medicine. A stroke damages the brain, and depending on which part was affected, it can change the ability to move, speak, swallow, and think. What you are watching is not a slow decline from illness — it is the aftermath of a sudden injury. Everything you are doing — being present, giving medications on time, keeping skin clean, talking to your person even when they cannot answer — is meaningful care that makes a real difference in their comfort and dignity.
What You May See
- Difficulty swallowing — coughing, choking, or a wet voice after eating: This is expected from brain damage affecting swallowing control. The techniques your speech therapist showed you reduce the risk significantly. Never leave your person unattended during meals.
- Weakness or paralysis on one side of the body: The affected arm and leg may have no voluntary movement. Positioning and gentle range-of-motion exercises prevent stiffness and skin problems. Your nurse will show you the schedule.
- Skin breakdown at bony areas — heel, tailbone, hip, shoulder blade: Daily skin inspection is essential. Call the nurse for any red area that does not lighten when you press on it. Repositioning every 2 hours is the most important thing you can do to prevent this.
- Difficulty speaking or understanding: Depending on the stroke location, your person may not speak, may say words that don't make sense, or may have difficulty understanding. They may still understand emotions, tone of voice, familiar music, and simple yes/no questions.
- Incontinence of bladder and bowel: Neurological control of these functions is affected. The products and routines your nurse arranged manage this safely. Skin care around these areas prevents breakdown.
- Emotional responses that seem sudden or extreme — crying or laughing without obvious cause: This is a known neurological symptom from the stroke itself and does not necessarily mean the person is in severe distress. Medication can help significantly — ask the nurse.
How You Can Help
- Give all medications on time and report any new swallowing difficulty: Have a backup plan ready as your nurse reviewed. If swallowing becomes worse, discuss alternative routes with the nurse before it becomes a crisis.
- Reposition every 2 hours — set a timer: Use the pillow placement your nurse showed you. This is the single most important thing you do to prevent painful skin breakdown. It matters more than almost anything else in daily care.
- Talk to your person — even if they cannot respond: Hearing is often preserved even when speech is lost. Use their name. Tell them about your day. Play their favorite music. Ask simple yes/no questions and wait — they may respond with eye movement, hand squeeze, or facial expression.
- Follow swallowing precautions exactly: Sit your person upright for all meals and medications. Use the thickened liquids and food textures the speech therapist recommended. Small bites. Watch for coughing or wet voice. If either occurs, stop and call the nurse.
- Take care of yourself — this is not optional: Caring for a stroke patient at home is physically and emotionally exhausting. Accept help when offered. Call us when you need support — not just when the patient does. You are part of this care team, and you cannot care for your person if you are depleted.
- Making decisions for your person is the hardest job in medicine: If you are making medical decisions because your person cannot speak, know this: you are not choosing what you want. You are choosing what your person would have wanted, based on everything you knew about them. That is an act of love. The hospice team is here to help you through every decision.
📞 Call the nurse immediately if you see:
Sudden new weakness, facial drooping, or speech change (possible new stroke — have a plan in place). Fever with worsening breathing or increased secretions (possible aspiration pneumonia). Seizure activity — jerking movements, staring, or loss of responsiveness — give buccal midazolam as instructed and call immediately. Skin breakdown — any open area or dark discoloration on the tailbone, heels, or hips. Sudden severe headache or vomiting (possible hemorrhagic event). Medications no longer being swallowed safely despite precautions. Any change that frightens you — trust your instincts and call.
🙏 Research consistently shows that patients who have family present have better symptom control, less anxiety, and more peaceful deaths. Your presence at the bedside is not just emotional — it is clinically meaningful. You are doing the most important work there is to do. The hospice team is here to support you, teach you, and stand with you through every stage of this journey.
Waldo's Top 10 Tips
Clinical field wisdom from 12+ years at the bedside. The things you learn after doing this long enough. Not guidelines — real.
- 01Aphasia is not absence. Never enter a post-stroke room and speak to the family about the patient as if the patient is not there. I don't care how severe the aphasia is. Sit close. Make eye contact. Say their name. Ask a yes/no question. Wait for the response — it may come as a hand squeeze, a blink, a facial expression. Model this for the family at every single visit. The family who learns that their aphasic person is still present — still listening, still feeling, still there — reconnects in a way that changes everything about their caregiving and everything about their grief. You teach that by doing it.
- 02Silent aspiration is the clinical trap. The absence of coughing does not mean swallowing is safe. I have lost count of how many times a family has told me "they eat fine, no coughing" and then the chest X-ray shows bilateral infiltrates from weeks of silent aspiration. The brain damage from stroke often includes the cough reflex circuits. Get a formal SLP swallowing assessment at enrollment — not next week, at enrollment. Look for the indirect signs: wet gurgling voice after eating, low-grade fevers that come and go, nocturnal coughing, weight loss nobody can explain. Treat the swallowing with the same clinical urgency as a wound.
- 03Secondary prevention deprescribing is your clinical job and it is almost never done. I see it constantly — the patient with mRS 5 on a statin, an antiplatelet, an antihypertensive, a DOAC, and two other agents prescribed after their first stroke five years ago. Nobody has touched that medication list since. The cardiologist prescribed it. The PCP renewed it. The rehab facility continued it. Now they're in hospice and the medication list is still optimized for a patient who was going to recover. Review every medication at enrollment. Deprescribe with documentation and explanation. The monitoring burden and pill burden reduction is a comfort intervention. The family needs to hear why you're stopping medications — not just that you are.
- 04The tube feeding conversation in stroke must be led by the clinical evidence. When the family asks about a PEG tube, they are not asking for nutrition — they are asking for hope, for control, for something to do when everything else has been taken away. Hear that. Then give them the facts: PEG does not prevent aspiration in severe post-stroke dysphagia. The FOOD trial showed this. Patients aspirate oral secretions and refluxed tube feed regardless of tube placement. Say it clearly and kindly. Then tell them what the tube does provide: reliable medication delivery, some nutritional support, and for some families, a sense of having done everything possible. Let them decide based on accurate information. A family that chooses PEG knowing the evidence has made an informed choice. A family that chooses PEG believing it will stop the pneumonias has not.
- 05The surrogate decision-maker in stroke almost never had the advance directive conversation. This is different from dementia where the family has had years to observe decline and often years of gradual role shifting. The stroke surrogate was a spouse or child one day and a medical power of attorney the next — making decisions about feeding tubes, medication changes, and do-not-resuscitate orders for a person who was at the dinner table last month. Help them construct substituted judgment: "Not what you want — what your person would have wanted. If they could see themselves right now, what would they tell you?" Walk them through it gently at every decision point. Document everything. And never — ever — let them feel like they are alone in these decisions.
- 06The alternating pressure mattress goes on at enrollment, not at the first wound. Every hemiplegic stroke patient who is bedbound gets an alternating pressure mattress ordered at enrollment visit. Not at the first reddened area. Not when the family mentions they saw something on the tailbone. At enrollment. The same visit. Also at that visit: demonstrate the repositioning schedule, place the heel pillows, and tell the family — plainly — that pressure injuries in this situation are extremely common, extremely painful, and extremely difficult to treat once they start, but largely preventable if we act now. Write the schedule on a whiteboard they can see from the bed. Make it the family's job with your supervision.
- 07Have the recurrent stroke conversation before the recurrent stroke. A patient who has already had one or more strokes is at significant risk for another one. If it happens, what does the family want? Hospital transfer? Thrombolysis attempt? Comfort at home? This is not a conversation to have during the event — it is a conversation to have at enrollment, calmly, with time to think. For a patient with mRS 5 and comfort-only goals, the answer is usually comfort at home — but the family needs to have said it out loud before the crisis arrives. Document it. Put it in the plan. Make sure the on-call team knows. I have seen families call 911 during a new stroke event because nobody had the conversation beforehand, and then they're in an ED they never wanted to be in.
- 08Racial disparities in stroke care are real and they follow the patient into hospice. Black and Hispanic patients have higher stroke incidence, receive less acute treatment (lower thrombolysis and thrombectomy rates), have less access to rehabilitation, and are referred to palliative care later. By the time they reach hospice, the cumulative effect of these disparities is written into their neurological deficit and their family's medical mistrust. Acknowledge this. Do not pretend the system has treated everyone equally. Provide culturally humble care. Ensure that language, religious tradition, and family structure are respected in the care plan. And recognize that the family's hesitation about medication changes or comfort-only goals may come from a history of being offered less care, not more.
- 09The caregiver of a stroke patient is carrying a physical burden unlike any other diagnosis. This is not metaphorical. A hemiplegic adult who needs repositioning every 2 hours, assisted transfers, feeding assistance, medication administration through a PEG, incontinence care, and skin inspection is generating a physical workload that would challenge a trained CNA. And the family caregiver has had no training, no warning, and often no help. Screen for caregiver exhaustion at every visit. Ask directly: "How are you sleeping? When did you last leave the house? Who helps you?" Respite is not a luxury — it is a clinical intervention that prevents caregiver collapse and patient harm.
- 10The person is still in there. I have sat with post-stroke patients who could not speak a word, could not move half their body, could not swallow their own saliva — and when their grandchild's voice came through the phone, they squeezed my hand. When their favorite song played, their eyes tracked to the speaker. When their spouse leaned in and said "I love you," their face changed in a way that cannot be explained by brainstem reflexes. The neuroscience of preserved awareness in severe stroke is complex and incomplete. But the clinical reality is simple: treat every patient as if they can hear you, feel you, and know you are there. Because they might. And if they can, the last thing they should hear is someone who cared enough to still be talking to them.
— Waldo, NP
References
Peer-reviewed citations. Based on articles retrieved from PubMed. All PMIDs hyperlinked. Evidence levels assigned by article type.
1
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics — 2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93-e621.
2
Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36(12):2756-2763.
3
Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011;42(5):1489-1494.
4
McInnes E, Jammali-Blasi A, Bell-Syer SE, Dumville JC, Middleton V, Cullum N. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev. 2015;(9):CD001735.
5
Creutzfeldt CJ, Holloway RG, Walker M. Symptomatic and palliative care for stroke survivors. J Gen Intern Med. 2012;27(7):853-860.
6
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines. Stroke. 2019;50(12):e344-e418.
7
Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293-298.
8
Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864-870.
9
Smithard DG, Smeeton NC, Wolfe CD. Long-term outcome after stroke: does dysphagia matter? Age Ageing. 2007;36(1):90-94.
10
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation (ARISTOTLE trial). N Engl J Med. 2011;365(11):981-992.
11
Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke. 2015;46(7):2032-2060.
12
Howard G, Cushman M, Kissela BM, et al. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011;42(12):3369-3375.
13
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data (HERMES). Lancet. 2016;387(10029):1723-1731.
14
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.
15
Jüttler E, Unterberg A, Woitzik J, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke (DESTINY II). N Engl J Med. 2014;370(12):1091-1100.
16
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (AHA/ASA). Stroke. 2014;45(7):2160-2236.
17
Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack (SPARCL). N Engl J Med. 2006;355(6):549-559.
18
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033-1041.
19
Lindsay P, Furie KL, Davis SM, et al. World Stroke Organization global stroke services guidelines and action plan. Int J Stroke. 2014;9 Suppl A100:4-13.
20
Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10(2):123-130.
21
Todd A, Husband A, Andrew I, Pearson SA, Keen F, Husband A. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2017;7(2):113-121.
22
Dennis MS, Lewis SC, Warlow C; FOOD Trial Collaboration. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet. 2005;365(9461):764-772.
23
Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology. 2016;86(19):1818-1826.
24
Simmons-Mackie N, Raymer A, Cherney LR. Communication Partner Training in Aphasia: An Updated Systematic Review. Arch Phys Med Rehabil. 2016;97(12):2202-2221.
25
Särkämö T, Tervaniemi M, Laitinen S, et al. Music listening enhances cognitive recovery and mood after middle cerebral artery stroke. Brain. 2008;131(Pt 3):866-876.
26
Pioro EP, Brooks BR, Cummings J, et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 2010;68(5):693-702.
27
Holloway RG, Arnold RM, Creutzfeldt CJ, et al. Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(6):1887-1916.
28
Twycross R, Wilcock A, Howard P. Palliative Care Formulary. 7th ed. Pharmaceutical Press. 2020.
29
Creutzfeldt CJ, Engelberg RA, Healey L, et al. Palliative Care Needs in the Neuro-ICU. Crit Care Med. 2015;43(8):1677-1684.
30
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY). N Engl J Med. 2009;361(12):1139-1151.
31
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF). N Engl J Med. 2011;365(10):883-891.
32
Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery (HAMLET): a randomised, open, phase 3 trial. Lancet Neurol. 2007;6(3):215-222.
33
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke (TOAST). Definitions for use in a multicenter clinical trial. Stroke. 1993;24(1):35-41.
34
Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke. 2014;9(8):1017-1025.
35
Harrison RA, Field TS. Post stroke pain: identification, assessment, and therapy. Cerebrovasc Dis. 2015;39(3-4):190-201.
36
Daniels SK, Foundas AL. Swallowing physiology of sequential straw drinking. Dysphagia. 2001;16(3):176-182.
37
NICE. Pressure ulcers: prevention and management. Clinical guideline [CG179]. National Institute for Health and Care Excellence. 2014.
38
Cichero JA, Lam P, Steele CM, et al. Development of International Terminology and Definitions for Texture-Modified Foods and Thickened Fluids Used in Dysphagia Management: The IDDSI Framework. Dysphagia. 2017;32(2):293-314.
39
Winstein CJ, Stein J, Arena R, et al. Guidelines for Adult Stroke Rehabilitation and Recovery (AHA/ASA). Stroke. 2016;47(6):e98-e169.
40
Duncan PW, Zorowitz R, Bates B, et al. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke. 2005;36(9):e100-e143.
41
Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis (ECASS, ATLANTIS, NINDS, EPITHET). Lancet. 2010;375(9727):1695-1703.
42
Luengo-Fernandez R, Paul NL, Gray AM, et al. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke. 2013;44(10):2854-2861.
43
Stemer A, Lyden P. Evolution of the thrombolytic treatment window for acute ischemic stroke. Curr Neurol Neurosci Rep. 2010;10(1):29-33.
44
Wein TH, Staub L, Felberg R, et al. Activation of emergency medical services for acute stroke in a nonurban population: the T.L.L. Temple Foundation Stroke Project. Stroke. 2000;31(8):1925-1928.
45
Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology. 2006;66(5):641-646.
terminal2.care content is for educational purposes and is not a substitute for clinical judgment. Based on articles retrieved from PubMed. © Terminal2 | terminal2.care
Private Notes
Session notes — not saved to any server. Clears when you close the tab.
Use this space for visit notes, clinical reminders, or patient-specific observations. This text is stored only in your browser session.